Elevated SAA levels have been observed in patients with renal cancer [10], melanoma [12], endometrial cancer [13], nasopharyngeal carcinoma [14], lung cancer [16], gastric cancer [17], colorectal cancer [27] and breast cancer [15]. This evidence concerns the gene SAA1 and breast carcinoma.